Home » VIDA Diagnostics’ Deep Learning Algorithm Gets FDA Clearance
VIDA Diagnostics’ Deep Learning Algorithm Gets FDA Clearance
The FDA has granted 510(k) clearance for VIDA Diagnostics’ VIDA algorithm, artificial intelligence-based (AI) software that analyzes lung scans.
The algorithm is an addition to the company’s LungPrint suite that helps to improve lung- imaging assessments by including disease probability and progression.
The AI-powered analysis “empowers physicians to develop personalized treatment plans that can improve outcomes and quality of life,” the company said.
Upcoming Events
-
07May
-
14May
-
30May